Business Description
Gabather AB
ISIN : SE0010869552
Compare
Compare
Traded in other countries / regions
GABA.Sweden5J2.Germany IPO Date
2020-08-13Description
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -1.25 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.6 | |||||
| 3-Year FCF Growth Rate | 8.9 | |||||
| 3-Year Book Growth Rate | -74.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.46 | |||||
| 9-Day RSI | 50.63 | |||||
| 14-Day RSI | 49.67 | |||||
| 6-1 Month Momentum % | -70.71 | |||||
| 12-1 Month Momentum % | -80.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.44 | |||||
| Quick Ratio | 0.44 | |||||
| Cash Ratio | 0.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | -6.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -191.62 | |||||
| ROIC % | -164.4 | |||||
| 3-Year ROIIC % | 64.93 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.45 | |||||
| EV-to-EBITDA | -1.45 | |||||
| EV-to-FCF | -1.73 | |||||
| Earnings Yield (Greenblatt) % | -69.16 | |||||
| FCF Yield % | -52.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gabather AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.055 | ||
| Beta | 0.65 | ||
| Volatility % | 174.92 | ||
| 14-Day RSI | 49.67 | ||
| 14-Day ATR (€) | 0.004501 | ||
| 20-Day SMA (€) | 0.02339 | ||
| 12-1 Month Momentum % | -80.53 | ||
| 52-Week Range (€) | 0.0134 - 0.228703 | ||
| Shares Outstanding (Mil) | 23.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gabather AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gabather AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gabather AB Frequently Asked Questions
What is Gabather AB(FRA:5J2)'s stock price today?
The current price of FRA:5J2 is €0.02. The 52 week high of FRA:5J2 is €0.23 and 52 week low is €0.01.
When is next earnings date of Gabather AB(FRA:5J2)?
The next earnings date of Gabather AB(FRA:5J2) is 2024-11-28.
Does Gabather AB(FRA:5J2) pay dividends? If so, how much?
Gabather AB(FRA:5J2) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers